Article Information
PubMed
Published By
History
- Received May 12, 2016
- Revision received February 3, 2017
- Accepted February 8, 2017
- Published online February 22, 2017.
Copyright & Usage
Copyright © 2017 Voutilainen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Merja H. Voutilainen1,2,
- Francesca De Lorenzo2,*,
- Polina Stepanova2,*,
- Susanne Bäck1,
- Li-Ying Yu2,
- Päivi Lindholm2,
- Eeva Pörsti1,
- Mart Saarma2,
- Pekka T. Männistö1 and
- Raimo K. Tuominen1
- 1Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Viikki Biocenter, University of Helsinki, FIN-00014 Helsinki, Finland
- 2Institute of Biotechnology, Viikki Biocenter, University of Helsinki, FIN-00014 Helsinki, Finland
- Correspondence should be addressed to Dr. Merja H. Voutilainen, PhD, Institute of Biotechnology, P.O. Box 56, University of Helsinki, FI-00014 Helsinki, Finland. E-mail: merja.h.voutilainen{at}helsinki.fi.
Author contributions
Author contributions: M.H.V., S.B., M.S., P.T.M., and R.K.T. designed research; M.H.V., F.D.L., P.S., S.B., L.Y., P.L., and E.P. performed research; M.H.V., F.D.L., P.S., S.B., L.Y., P.L., and E.P. analyzed data; M.H.V., M.S., P.T.M., and R.K.T. wrote the paper.
↵* F.D.L. and P.S. contributed equally to this work.
Disclosures
MHV, PL, MS and RKT are inventors of the CDNF-patent, which is owned by Herantis Pharma Plc. MS is a shareholder of Herantis Pharma Plc.
The study was supported by grants from the Jane and Aatos Erkko Foundation, Michael J. Fox Foundation for Parkinson’s Research, Eu-ERA-NET, Sigrid Jusélius Foundation, and the Academy of Finland. M.H.V. was supported by grants from the Finnish Cultural Foundation and Finnish Parkinson Foundation.
Funding
Jane and Aatos Erkko Foundation
Michael J. Fox Foundation
EU-Era-Net Neuron
Sigrid Juselius Foundation
Academy of Finland
Finnis Cultural Foundation
Finnish Parkinson Foundation
Other Version
- You are viewing the most recent version of this article.
- previous version (February 22, 2017).
Online Impact
Article usage
In this issue
Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action
